Target intelligence / Profile preview

Human cancer cell lines

Molecular classification
Other
01

Overview

Human cancer cell lines are immortalized cell populations derived from human tumors that are capable of indefinite proliferation in laboratory cultures (Masters, 2000, Nature Reviews Cancer). They serve as the workhorse of oncology research, providing a scalable and reproducible platform for studying cancer biology and evaluating the efficacy of potential therapeutic agents (Gillet et al., 2013, Journal of the National Cancer Institute). These cell lines are used in high-throughput screening to identify compounds that inhibit cell growth or induce cell death, often through specific molecular targets like kinases or receptors (NCI-60 Human Tumor Cell Line Screen, NIH). While they are essential for early-stage drug discovery, they are considered experimental models rather than therapeutic targets themselves. A significant challenge in using these lines is that they often fail to capture the complexity of the tumor microenvironment and can undergo genetic drift, leading to results that may not translate to clinical settings (Ben-David et al., 2018, Nature). Furthermore, cross-contamination and misidentification remain persistent issues in the field, necessitating rigorous authentication (Capes-Davis et al., 2010, International Journal of Cancer).

Other names
Cancer cell linesTumor cell linesImmortalized human cancer cellsNCI-60 panel
02

Mechanism of action

Not applicable; human cancer cell lines are experimental model systems used to evaluate drug effects rather than being molecular targets themselves.

03

Biological functions

Cell proliferationCell cycleApoptosisSignal transductionMetabolism
04

Disease associations

Cancer
05

Safety considerations

Genetic drift over successive passagesLack of tumor microenvironment and stromal interactionsCross-contamination and misidentification of cell linesPoor translation from in vitro results to in vivo clinical outcomes
06

Interacting drugs

Paclitaxel

6 more in the full profile.

07

Biomarkers

TP53 mutation statusKRAS mutation statusBRAF V600E mutationHER2/neu amplificationMicrosatellite instability (MSI)

Beyond the preview

Go deeper on Human cancer cell lines.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human cancer cell lines.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call